Trivendra Tripathi

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsHaematologyTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 13, 2024
Dual Checkpoint Aptamer Immunotherapy: Unveiling Tailored Cancer Treatment Targeting CTLA-4 and NKG2A.

Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko

|Sep 28, 2023
New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote.

Mohamad Ammar Ayass, Natalya Griko, Victor Pashkov

|Apr 14, 2022
A Single-Domain TCR-like Antibody Selective for the Qa-1<sup>b</sup>/Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint.

Soroush Ghaffari, Katherine Upchurch-Ange, Susanne Gimlin

|Jun 27, 2019
Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.

Trivendra Tripathi, Wenjie Yin, Yaming Xue

Pageof 1

Frequent Collaborators

1 joint publications

Wenjie Yin

1 joint publications

Katherine Upchurch-Ange

1 joint publications

Jim Middelburg

1 joint publications

Thorbald van Hall